Trinity Biotech | TRIB - Current Liabilities


Trinity Biotech reported $143.68M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Abbott USD 16.15B 1.66B Sep/2026
Bayer EUR 29.4B 2.87B Sep/2026
Bio-Rad Laboratories USD 969.1M 7.8M Sep/2026
EDAP TMS EUR 37.51M 6.1M Mar/2026
J&J USD 55.46B 562M Sep/2026
Mesa Laboratories USD 54.4M 6.1M Dec/2025
OraSure Technologies USD 25.12M 18.96M Jun/2026
Plus Therapeutics USD 8.57M 612K Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Siemens EUR 45.11B 4.4B Jun/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Tosoh JPY 404.7B 12.78B Sep/2026
Trinity Biotech USD 143.68M 2.48M Mar/2026
Veracyte USD 84.21M 21.47M Sep/2026